Literature DB >> 16199813

Mesothelioma: time to take stock.

Carol Tan1, Tom Treasure.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16199813      PMCID： PMC1240101          DOI： 10.1177/014107680509801010

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  21 in total

Review 1.  Pleural mesothelioma: little evidence, still time to do trials.

Authors:  Tom Treasure; Artyom Sedrakyan
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

2.  Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

Authors:  E G Butchart; T Ashcroft; W C Barnsley; M P Holden
Journal:  Thorax       Date:  1976-02       Impact factor: 9.139

Review 3.  A review of chemotherapy trials for malignant mesothelioma.

Authors:  C W Ryan; J Herndon; N J Vogelzang
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

4.  Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.

Authors:  O Soysal; N Karaoğlanoğlu; S Demiracan; S Topçu; I Taştepe; S Kaya; M Unlü; G Cetin
Journal:  Eur J Cardiothorac Surg       Date:  1997-02       Impact factor: 4.191

5.  Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

Authors:  Walter Weder; Peter Kestenholz; Christian Taverna; Stefan Bodis; Didier Lardinois; Monika Jerman; Rolf A Stahel
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

6.  Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.

Authors:  Kenneth M Forster; W Roy Smythe; George Starkschall; Zhongxing Liao; Tsuyoshi Takanaka; Jason F Kelly; Ara Vaporciyan; Anesa Ahamad; Lei Dong; Mohammad Salehpour; Ritsuko Komaki; Craig W Stevens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

7.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Authors:  Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.

Authors:  Samuel G Armato; Geoffrey R Oxnard; Heber MacMahon; Nicholas J Vogelzang; Hedy L Kindler; Masha Kocherginsky; Adam Starkey
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

9.  Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.

Authors:  C Boutin; F Rey; J R Viallat
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

10.  Continuing increase in mesothelioma mortality in Britain.

Authors:  J Peto; J T Hodgson; F E Matthews; J R Jones
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321
View more
  5 in total

1.  Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancer.

Authors:  Sarah L Suchy; Rodney J Landreneau; Matthew J Schuchert; Dakun Wang; Paul R Ervin; Stacey L Brower
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

Review 2.  The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Tumour Biol       Date:  2013-10-01

3.  Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells.

Authors:  Venerando Rapisarda; Rossella Salemi; Andrea Marconi; Carla Loreto; Adriana C Graziano; Venera Cardile; Maria S Basile; Saverio Candido; Luca Falzone; Demetrios A Spandidos; Concettina Fenga; Massimo Libra
Journal:  Oncol Lett       Date:  2016-08-26       Impact factor: 2.967

Review 4.  Occupational exposure to carcinogens: Benzene, pesticides and fibers (Review).

Authors:  Luca Falzone; Andrea Marconi; Carla Loreto; Sabrina Franco; Demetrios A Spandidos; Massimo Libra
Journal:  Mol Med Rep       Date:  2016-10-03       Impact factor: 2.952

Review 5.  Overview of the biochemical and genetic processes in malignant mesothelioma.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.